The UK Government has launched a review of business-university growth opportunities, led by GlaxoSmithKline chief executive Sir Andrew Witty. The report aims to address failings in the UK to commercialise university research by cultivating links with more local businesses surround the UK’s research hubs. Sir Witty, who is also chancellor of the University of Nottingham,…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
